Automotive Parts Industry
Yuan Feng Ind. Co., Lt.
Ton Yang Group
   
Research and Development Services Industry
Protech Pharmaservice Corporation ( PPC)
Asia-Pacific Technology & Intellectual Property Services Inc.
NOVA Design
   
   
   
 

Protech Pharmaservice Corporation (PPC)

 
 

Creativity and Insightful opinions Becoming A Benchmark in the Biomedical Industry

   
 

◎ Writer / Li-ci Lin ◎ Photographer / Jhih-gang Li

   
 

Protech Pharmaservice Corporation, founded in 1997, developed from a small company with 14 employees and capital of NT$50 million to an enterprise with 210 employees and capital of NT$240 billion. Its annual turnover multiplied over the years. This year its turnover is expected to reach NT$ 400 billion.

Over the last 10 years, PPC not only made achievements in its operation but also found an aspect for the Taiwan biomedical industry to put effort in to build up its strength to enter the Asian and even the world biomedical industry-Contract Research Organization (CRO).

In the past few years, it was due to President Jason Chen's daring and superior judgment that PPC reached such a great achievement. When the biomedical industry was burgeoning, he led his business with unyielding faith although the future of this industry was dim. The biomedical industry in Taiwan has not yet prospered. The experience of the rapid rise of PPC is now a legend in this industry.
 
 
 
 

Creativity and Insightful Opinions Fulfill A Business' Mission .
Jason Chen, a graduate of the Department of Pharmacy of Taipei Medical College , has long persisted in the biomedical industry. As a Pharmacy graduate, he had the vision of a bright outlook of the biomedical industry ten years ago. He believed that the electronic manufacturing industry might be the star industry at that time, but the future trend would definitely turn to technology based R&D service industry. What kind of roles were related industries in Taiwan going to play in this predictable trend? Jason, with his experiences and sharp instincts, chose to invest in the niche market of CRO.

A general definition of CRO is an authorized research institution which offers technical support to biomedical related fields in the business circle, political circle and academia. The development of new medicine or material often requires a large amount of cost and the risks are very high. The success rate is only between 5-10%. However, the niche market of CRO is a stable market because it is protected by the contracts and does not have to take on the high risks of researching and developing new medicine. If a pharmaceutical factory or a research institution can contract its tests to be implemented and managed by a CRO, through CRO's strict medical process and regulations, it can save a lot of labor force and material resources, have its quality internationally recognized, and shorten the time needed to research and develop new medicine and also the time to enter the market.
 
 
 

 

 

In a promising industry and with an insightful leader, PPC has become one of the biggest contract research organizations in Asia . It provides full scale services to the biomedical industry, including clinical trial and research, medicine core laboratory test, estimation on the medicine market economy and pharmacokinetics research. PPC dominates more than half of the market of contracting BE (Bioequivalence) tests, BA (Bioavailability) tests, application for new medicine examination and PK tests (Pharmacokinetic Study).

   
   
 
    1 2 3
   
Endorsed by:Department of Industrial Technology  /  Executed by:China Productivity Center  Copyright © 2004